Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Zonisamide Treatment of Alcohol Use Disorder: an Evaluation of Efficacy and Mechanism of Action

NCT02900352 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.

NCT NCT02900352
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02900352 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Zonisamide Treatment of Alcohol Use Disorder: an Evaluation of Efficacy and Mechanism of Action
Lead sponsor
Virginia Commonwealth University
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2016
Completion date
April 22, 2021
Enrollment
156 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder